4//SEC Filing
Polymeropoulos Mihael Hristos 4
Accession 0000950170-25-032276
CIK 0001347178other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:45 PM ET
Size
6.7 KB
Accession
0000950170-25-032276
Insider Transaction Report
Form 4
Polymeropoulos Mihael Hristos
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-03-03$4.71/sh+10,000$47,050→ 2,275,731 total - Tax Payment
Common Stock
2025-03-01$4.76/sh−95,999$456,955→ 2,265,731 total
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.69 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001355537
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:45 PM ET
- Size
- 6.7 KB